Blue Matter will attend and speak at the Why? Summits 35th European Pharma and Biotech Project, Program and Portfolio Management Conference in London, October 20-21, 2026.
Blue Matter Managing Partner, Antonio Iervolino, will deliver a presentation on Tuesday, Oct. 20 at 2:00 pm:
Right Bet, Right Money, Right Time: What 400 Launches Reveal About the Quality of Our Portfolio Decisions
Every portfolio decision rests on a forecast, and launch is where that forecast meets reality. Blue Matter has benchmarked 400 launches against the expectations that justified them and combined the findings with new research among senior launch leaders across pharma and biotech. This session uses that evidence to test how well our strategic choices hold up in hindsight. Did we back the right assets, fund them at the right level, and commit the money at the right moment? It pinpoints where value is won and lost in the years either side of launch and shows how leaders can take smarter risks by matching each investment to the value and uncertainty of the bet.
Attendees will leave with:
- An evidence base from 400 launches for judging portfolio decisions against real market outcomes
- Early warning signals that flag, at the point of prioritisation, the assets most likely to under-deliver
- A practical framework for sizing and timing launch investment: what to commit early, what to stage, and what evidence should release the next tranche
